comparemela.com
  1. Home
  2. Live Updates
  3. Tingbo Liang - Breaking News

Latest Breaking News On - Tingbo liang - Page 1 : comparemela.com

Innovent Presents Phase 1 Clinical Data of First-in-class PD-1/IL-2α Bispecific Antibody Fusion Protein (IBI363) in Melanoma, Colorectal Cancer and other Solid Tumors at the 2024 ASCO Annual Meeting

/PRNewswire/ Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes.

Yu chenRhui zhouUnited statesInnovent biologicsTingbo liangSanofi incyteEli lillyPrnewswire innovent biologics incZhejiang universitySchool of medicineEuropean society for medical oncologyMd anderson cancer centerEuropean societyMedical oncologyVirtual plenarySenior vice president

Sintilimab Improves Response to Chemotherapy in Advanced Pancreatic Cancer

Adding sintilimab to chemotherapy improved responses, but not survival outcomes, in patients with advanced pancreatic adenocarcinoma.

Tingbo liangCancers symposiumCancer therapy advisorFirst affiliatedZhejiang university school

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.